Atlas Trials

Inectolizumab With Steroid Optimization in Newly Treated NMOSD

Clinical trial NCT07159893 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07159893
Sponsor
First Affiliated Hospital of Wenzhou Medical University
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Neuromyelitis OpticaAutoimmune DiseasesDemyelinating Autoimmune Diseases, CNS
Start date
2025-09-01
Primary completion
2026-05-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.